Yanelys Morera Díaz

Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial

Jorge Gavilondo, Francisco Hernández‐Bernal, Marta Ayala‐Ávila et al. · Vaccine · 2014 · 48 citations

Vegf Vaccine, Specific Active Immunotherapy, Tumor Immunology +11

Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants

Yanelys Morera Díaz, Mónica Béquet‐Romero, Marta Ayala et al. · Angiogenesis · 2008 · 37 citations

Cancer Immunosurveillance, Active Immunotherapy, Medicine +12

In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein

Nelson Acosta‐Rivero, Armando Rodríguez, Alexis Musacchio et al. · Biochemical and Biophysical Research Communications · 2004 · 35 citations

Viral Replication, Natural Sciences, Biotechnology +10

CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors

Mónica Béquet‐Romero, Yanelys Morera Díaz, Marta Ayala‐Ávila et al. · Vaccine · 2012 · 33 citations

Tumor Biology, Immunology, Spontaneous Lung Metastasis +9

Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine

Yanelys Morera Díaz, Javier Sánchez Ramírez, Mónica Béquet‐Romero et al. · Vaccine · 2017 · 33 citations

Vaccination, Cancer Immunosurveillance, Humoral Response +13